Ingenuity Announces Licensing Agreement with Boehringer Ingelheim
News Apr 19, 2006
Ingenuity Systems has announced that they have entered into an agreement with Boehringer Ingelheim for global access to Ingenuity Pathways Analysis (IPA) software.
"Boehringer Ingelheim's research teams will now have broad access to IPA globally at all sites," stated Peter DiLaura, Vice President, Sales and Customer Support.
"By integrating IPA into their workflows, researchers will shorten the time between data generation and biological interpretation. This value comes from the ability to understand biology at multiple levels - molecular interactions, association with cellular phenotypes, and understanding disease processes."
Ingenuity Pathways Analysis is a software application that is designed to enable researchers to model, analyze and understand the complex biological systems at the core of life science research.
IPA is deployed in most major pharmaceutical companies and hundreds of biotechnology companies and academic institutions globally.
It supports analysis of all high throughput analysis platforms and is used in virtually all areas of drug discovery and development from target identification and validation to biomarkers, predictive toxicology, and pharmacogenomics.
Ingenuity Pathways Analysis is available as a web-delivered, hosted, or deployed solution. Fully functional complimentary trials are available online.
New evidence published in the Cochrane Library provides high quality evidence that people who use a combination of nicotine replacement therapies (a patch plus a short acting form, such as gum or lozenge) are more likely to successfully quit smoking than people who use a single form of the medicine.READ MORE
When a protein named "Merlin" fails to do its job, people can develop slow-growing, life-disrupting auditory nerve tumors that can disrupt their hearing and balance. Now scientists at Cincinnati Children's have discovered much more about how Merlin does its job – by working behind the scenes through a network of more than 50 other proteins.READ MORE